Back

Lifelong anticoagulation is the best option after unprovoked venous thromboembolism - Discussion

1 September 2019 (11:30 - 11:45)
Organised by:
Congress Presentation Part of: Controversies in the management of pulmonary hypertension and venous thromboembolism Treatment ESC Premium Access ESC Congress 2019

5 More presentations in this session

Presentation thumbnail
Lifelong anticoagulation is the best option after unprovoked venous thromboembolism - PRO
Professor L. Mazzolai (Lausanne, CH)
Slides Video
Presentation thumbnail
Lifelong anticoagulation is the best option after unprovoked venous thromboembolism - CON
Professor N. Meneveau (Besancon, FR)
Slides Video
Presentation thumbnail
Pulmonary hypertension due to left heart disease should be treated with drugs approved for idiopathic pulmonary arterial hypertension - PRO
Professor S. Rosenkranz (Cologne, DE)
Presentation thumbnail
Pulmonary hypertension due to left heart disease should be treated with drugs approved for idiopathic pulmonary arterial hypertension - CON
Doctor J. Bermejo Thomas (Madrid, ES)
Slides Video
Presentation thumbnail
Pulmonary hypertension due to left heart disease should be treated with drugs approved for idiopathic pulmonary arterial hypertension - Discussion
Video

Access the full session

Session thumbnail
Controversies in the management of pulmonary hypertension and venous thromboembolism

The Event

Event poster

ESC Congress 2019

1 September 2019 11:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources